These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 33915202)

  • 1. Lipid homeostasis and mevalonate pathway in COVID-19: Basic concepts and potential therapeutic targets.
    Proto MC; Fiore D; Piscopo C; Pagano C; Galgani M; Bruzzaniti S; Laezza C; Gazzerro P; Bifulco M
    Prog Lipid Res; 2021 Apr; 82():101099. PubMed ID: 33915202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic and Clinical Observations of Mevalonate Depletion on the Mevalonate Signaling Pathway.
    Muller AL; Freed DH
    Curr Mol Pharmacol; 2017; 10(1):6-12. PubMed ID: 26758946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel prospects of statins as therapeutic agents in cancer.
    Pisanti S; Picardi P; Ciaglia E; D'Alessandro A; Bifulco M
    Pharmacol Res; 2014 Oct; 88():84-98. PubMed ID: 25009097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins.
    Iannelli F; Lombardi R; Milone MR; Pucci B; De Rienzo S; Budillon A; Bruzzese F
    Recent Pat Anticancer Drug Discov; 2018; 13(2):184-200. PubMed ID: 29189178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perturbed Lipid Metabolism Transduction Pathways in SARS-CoV-2 Infection and Their Possible Treating Nutraceuticals.
    Shukla A; Singh A; Tripathi S
    J Am Nutr Assoc; 2024; 43(7):614-626. PubMed ID: 38805016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New lipid-lowering agents acting on LDL receptors.
    Scharnagl H; März W
    Curr Top Med Chem; 2005; 5(3):233-42. PubMed ID: 15857307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond lipid-lowering: effects of statins on endothelial nitric oxide.
    Laufs U
    Eur J Clin Pharmacol; 2003 Mar; 58(11):719-31. PubMed ID: 12634978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins, Mevalonate Pathway and its Intermediate Products in Placental Development and Preeclampsia.
    Ermini L; Post M; Caniggia I
    Curr Mol Pharmacol; 2017; 10(2):152-160. PubMed ID: 26758951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mevalonate pathway, selenoproteins, redox balance, immune system, Covid-19: Reasoning about connections.
    Minetti G
    Med Hypotheses; 2020 Nov; 144():110128. PubMed ID: 32758903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interconnection of Estrogen/Testosterone Metabolism and Mevalonate Pathway in Breast and Prostate Cancers.
    Mokarram P; Alizadeh J; Razban V; Barazeh M; Solomon C; Kavousipour S
    Curr Mol Pharmacol; 2017; 10(2):86-114. PubMed ID: 26758947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current insights into pathogenesis of Parkinson's disease: Approach to mevalonate pathway and protective role of statins.
    Saeedi Saravi SS; Saeedi Saravi SS; Khoshbin K; Dehpour AR
    Biomed Pharmacother; 2017 Jun; 90():724-730. PubMed ID: 28419968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins: pros and cons.
    Pinal-Fernandez I; Casal-Dominguez M; Mammen AL
    Med Clin (Barc); 2018 May; 150(10):398-402. PubMed ID: 29292104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products.
    Diomede L; Albani D; Sottocorno M; Donati MB; Bianchi M; Fruscella P; Salmona M
    Arterioscler Thromb Vasc Biol; 2001 Aug; 21(8):1327-32. PubMed ID: 11498461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory effects of HMG-CoA reductase inhibitors.
    Danesh FR; Anel RL; Zeng L; Lomasney J; Sahai A; Kanwar YS
    Arch Immunol Ther Exp (Warsz); 2003; 51(3):139-48. PubMed ID: 12894868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of different inflammatory diseases by impacting the mevalonate pathway.
    Zeiser R; Maas K; Youssef S; Dürr C; Steinman L; Negrin RS
    Immunology; 2009 May; 127(1):18-25. PubMed ID: 19191903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins: perspectives in cancer therapeutics.
    Corcos L; Le Jossic-Corcos C
    Dig Liver Dis; 2013 Oct; 45(10):795-802. PubMed ID: 23490341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could drugs inhibiting the mevalonate pathway also target cancer stem cells?
    Likus W; Siemianowicz K; Bieńk K; Pakuła M; Pathak H; Dutta C; Wang Q; Shojaei S; Assaraf YG; Ghavami S; Cieślar-Pobuda A; Łos MJ
    Drug Resist Updat; 2016 Mar; 25():13-25. PubMed ID: 27155373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins inhibit blastocyst formation by preventing geranylgeranylation.
    Alarcon VB; Marikawa Y
    Mol Hum Reprod; 2016 May; 22(5):350-63. PubMed ID: 26908642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention.
    Mo H; Elson CE
    Exp Biol Med (Maywood); 2004 Jul; 229(7):567-85. PubMed ID: 15229351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mevalonate Cascade and Neurodevelopmental and Neurodegenerative Diseases: Future Targets for Therapeutic Application.
    Jiao X; Ashtari N; Rahimi-Balaei M; Chen QM; Badbezanchi I; Shojaei S; Marzban A; Mirzaei N; Chung S; Guan T; Li J; Vriend J; Mehr SE; Kong J; Marzban H
    Curr Mol Pharmacol; 2017; 10(2):115-140. PubMed ID: 26758948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.